Consumer perceptions of risk and required cost savings for generic prescription drugs

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)

Volumn 40, Issue 3, 2000, Pages 378-383

  Ganther, Julie M ^a,b   Kreling, David H ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ADULT; AGED; ARTICLE; COST CONTROL; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRESCRIPTION; RISK; UNITED STATES;

ADULT; AGED; COST SAVINGS; CROSS-SECTIONAL STUDIES; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRESCRIPTIONS, DRUG; RISK; WISCONSIN;

EID: 0034186241     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1086-5802(16)31086-5     Document Type: Article

References (23)

1. A. Neff T. Simpson Drug substitution rate advances: market measures Drug Topics. 136 February 17 1992 16 19
2. D. Vaczek Plans squeeze generic profitability Am Druggist. 212 September 1995 40 45
3. J.R. Bettman Perceived risk and its components: a model and empirical test J Market Res. 10 1973 381 385
4. J.P. Peter M.J. Ryan An investigation of perceived risk at the brand level J Market Res. 13 1976 184 188
5. W.O. Bearden J.B. Mason Consumer-perceived risk and attitudes toward generically prescribed drugs J Applied Psychol. 63 6 1978 741 746
6. Z.V. Lambert P.L. Doering E. Goldstein W.C. McCormick Predispositions toward generic drug acceptance J Consumer Res. 7 June 1980 14 22
7. N.V. Carroll R. Jang Consumer awareness of generic prescription drugs Contemp Pharm Pract. 4 3 1981 155 159
8. M. Podulka K. Krautkramer D. Amerson Consumers' attitudes toward generic drugs J Pharm Market Manag. 4 1 1989 93 104
9. D.H. Tootelian R.M. Gaedeke J. Schlacter Branded versus generic prescription drugs: perceptions of risk, efficacy, safety, and value J Health Care Market. 8 3 1988 26 29
10. J.M. Ganther The Effect of a Change in Prescription Drug Insurance Benefits on Consumer Purchase of Generic Prescription Drugs [master's thesis] 1996 University of Wisconsin Madison, Wisc
11. A.A. Nelson J.P. Gagnon Saliency of cost in the acceptance of a chemically equivalent drug on a prescription Med Market Media. 9 August 1974 17 31
12. N.V. Carroll C. Siridhara J.E. Fincham Factors affecting market acceptance of generic drug products: an examination of inherent risk, cost, and maximum allowable cost coverage Akron Bus Econ Rev. 18 1 1987 11 18
13. E. Brigham L. Gapenski Financial Management—Theory and Practice 1994 Dryden Press Fort Worth
14. W.N. Evans W.K. Viscusi Income effects and the value of health J Human Resources. 28 3 1993 497 518
15. J.E. Stafford B.M. Enis The cost quality relationship: an extension J Market Res. 6 1969 456 458
16. J.J. Wheatley J.S.Y. Chiu The effects of cost, store image, and product and respondent characteristics on perceptions of quality J Market Res. 14 1977 181 186
17. J.J. Wheatley J.S.Y. Chiu A. Goldman Physical quality, cost and perceptions of product quality: implications for retailers J Retailing. 57 2 1981 100 116
18. A.R. Rao K.B. Monroe The effect of cost, brand name and store name on buyers; perceptions of product quality: an integrative review J Market Res. 26 1989 351 357
19. W.B. Dodds K.B. Monroe D. Grewal Effects of cost, brand, and store information on buyers' product evaluations J Market Res. 27 1991 307 319
20. P. Slovic N. Kraus H. Lappe M. Major Risk perceptions of prescription drugs: report on a survey in Canada Can J Public Health. 82 May/June 1991 S15 S20
21. G.A. Churchill Marketing Research Methodological Foundations 1987 Dryden Press Orlando, Fla 328-329
22. N.V. Carroll A.W. Jowdy Demographic and prescription patronage motive differences among segments in the community pharmacy market J Pharm Market Manag. 1 4 1987 19 34
23. J.W. Wiederholt Development of an instrument to measure evaluative criteria that patients use in selecting a pharmacy for obtaining prescription drugs J Pharm Market Manag. 1 4 1987 35 60